Astrana Health Inc (ASTH)

Cost of Revenue

$868.50M

Quarterly · Period ending: · USD

ASTH logo

ASTH Cost of Revenue

Latest reported$868.50M
ASTH Quarterly Cost of Revenue ($136.21M → $868.50M)
High-resolution chart · PNG

ASTH cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Astrana Health Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
868,498,000
874,835,000
871,884,000
874,451,000
576,839,000
549,061,000
602,193,000
405,218,000
420,246,000
335,495,000
314,055,000
275,375,000
292,876,000
289,397,000
253,119,000
240,768,000
230,070,000
220,730,000
171,839,000
147,473,000
136,214,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.